Avanos Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,172	522	732	1,036	1,259	1,671
Market Cap Growth	103.09%	-28.70%	-29.35%	-17.74%	-24.67%	-23.98%
Enterprise Value	1,245	542.61	773.93	1,136	1,390	1,726
Last Close Price	25.03	11.23	15.92	22.43	27.06	34.67
PE Ratio	-	-	-	-	25.29	-
Forward PE	21.77	11.70	10.10	15.65	15.89	23.16
PEG Ratio	-	2.70	0.48	2.34	0.89	1.30
PS Ratio	1.64	0.74	1.06	1.54	1.84	2.85
PB Ratio	1.49	0.67	0.88	0.84	0.98	1.32
P/TBV Ratio	1.49	0.67	0.88	0.85	0.99	1.33
P/FCF Ratio	156.27	12.10	8.83	70.94	17.58	25.21
P/OCF Ratio	31.94	6.98	7.27	31.97	13.85	19.14
EV/Sales Ratio	1.74	0.77	1.13	1.69	2.03	2.94
EV/EBITDA Ratio	22.27	-	-	22.58	16.71	-
EV/EBIT Ratio	75.90	-	-	270.40	39.16	-
EV/FCF Ratio	165.98	12.59	9.34	77.79	19.42	26.03
Debt / Equity Ratio	0.15	0.14	0.18	0.15	0.20	0.14
Debt / EBITDA Ratio	-	-	-	4.16	3.33	-
Debt / FCF Ratio	18.45	3.00	2.05	14.32	3.87	2.83
Net Debt / Equity Ratio	0.09	0.05	0.08	0.10	0.12	0.05
Net Debt / EBITDA Ratio	-3.10	-1.73	-0.18	2.41	1.79	-98.57
Net Debt / FCF Ratio	9.71	0.91	0.75	8.32	2.09	1.04
Asset Turnover	0.67	0.63	0.48	0.39	0.40	0.36
Inventory Turnover	2.47	2.42	2.03	1.99	1.99	1.75
Quick Ratio	1.29	1.17	1.45	0.98	1.55	1.79
Current Ratio	2.48	2.15	2.37	2.08	3.27	3.07
Return on Equity (ROE)	-10.19%	-9.07%	-37.42%	-0.78%	1.68%	-2.45%
Return on Assets (ROA)	-6.25%	-6.09%	-26.66%	0.30%	1.69%	-1.75%
Return on Invested Capital (ROIC)	-7.75%	-7.81%	-32.21%	0.36%	2.00%	-2.07%
Return on Capital Employed (ROCE)	-6.90%	-6.50%	-32.39%	0.28%	2.32%	-2.63%
Earnings Yield	-	-	-	-	3.95%	-
FCF Yield	0.64%	8.26%	11.33%	1.41%	5.69%	3.97%
Buyback Yield / Dilution	-0.92%	-0.65%	1.29%	1.48%	2.67%	-1.67%
Total Shareholder Return	-0.92%	-0.65%	1.29%	1.48%	2.67%	-1.67%

SEC Filings: 10-K · 10-Q